125 related articles for article (PubMed ID: 7935164)
1. Immunogenicity of a viral model vaccine after different inactivation procedures.
Bachmann MF; Bast C; Hengartner H; Zinkernagel RM
Med Microbiol Immunol; 1994 May; 183(2):95-104. PubMed ID: 7935164
[TBL] [Abstract][Full Text] [Related]
2. Formalin inactivation of vesicular stomatitis virus impairs T-cell- but not T-help-independent B-cell responses.
Bachmann MF; Kündig TM; Kalberer CP; Hengartner H; Zinkernagel RM
J Virol; 1993 Jul; 67(7):3917-22. PubMed ID: 8389912
[TBL] [Abstract][Full Text] [Related]
3. Induction of protective cytotoxic T cells with viral proteins.
Bachmann MF; Kündig TM; Freer G; Li Y; Kang CY; Bishop DH; Hengartner H; Zinkernagel RM
Eur J Immunol; 1994 Sep; 24(9):2228-36. PubMed ID: 8088338
[TBL] [Abstract][Full Text] [Related]
4. Immunization with recombinant protein: conditions for cytotoxic T cell and/or antibody induction.
Bachmann MF; Hengartner H; Zinkernagel RM
Med Microbiol Immunol; 1994 Dec; 183(6):315-24. PubMed ID: 7596314
[TBL] [Abstract][Full Text] [Related]
5. Induction of protective cytotoxic T cell responses in the presence of high titers of virus-neutralizing antibodies: implications for passive and active immunization.
Seiler P; Bründler MA; Zimmermann C; Weibel D; Bruns M; Hengartner H; Zinkernagel RM
J Exp Med; 1998 Feb; 187(4):649-54. PubMed ID: 9463415
[TBL] [Abstract][Full Text] [Related]
6. Vesicular stomatitis virus Indiana glycoprotein as a T-cell-dependent and -independent antigen.
Freer G; Burkhart C; Ciernik I; Bachmann MF; Hengartner H; Zinkernagel RM
J Virol; 1994 Jun; 68(6):3650-5. PubMed ID: 7910641
[TBL] [Abstract][Full Text] [Related]
7. Role of de novo protein synthesis in target cells recognized by cytotoxic T lymphocytes specific for vesicular stomatitis virus.
Roscoe DM; Ishikawa K; Lyles DS
J Virol; 1991 Dec; 65(12):6856-61. PubMed ID: 1658379
[TBL] [Abstract][Full Text] [Related]
8. The role of antibodies in natural and acquired resistance of mice to vesicular stomatitis virus.
Gobet R; Cerny A; Rüedi E; Hengartner H; Zinkernagel RM
Exp Cell Biol; 1988; 56(4):175-80. PubMed ID: 2849570
[TBL] [Abstract][Full Text] [Related]
9. Role of T helper cell precursor frequency on vesicular stomatitis virus neutralizing antibody responses in a T cell receptor beta chain transgenic mouse.
Freer G; Burkhart C; Rülicke T; Ghelardi E; Rohrer UH; Pircher H; Zinkernagel RM; Hengartner H
Eur J Immunol; 1995 May; 25(5):1410-6. PubMed ID: 7539759
[TBL] [Abstract][Full Text] [Related]
10. T helper cells in cytotoxic T lymphocyte development: role of L3T4(+)-dependent and -independent T helper cell pathways in virus-specific and alloreactive cytotoxic T lymphocyte responses.
Ciavarra RP
Cell Immunol; 1990 Feb; 125(2):363-79. PubMed ID: 2153464
[TBL] [Abstract][Full Text] [Related]
11. Localization of T helper cell epitopes in the vesicular stomatitis virus: the nucleoprotein is responsible for serotype cross-reactive T help.
Burkhart C; Freer G; Steinhoff U; Li Y; Bishop DH; Zinkernagel RM; Hengartner H
Viral Immunol; 1994; 7(3):103-11. PubMed ID: 7541205
[TBL] [Abstract][Full Text] [Related]
12. T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction?
Bachmann MF; Hengartner H; Zinkernagel RM
Eur J Immunol; 1995 Dec; 25(12):3445-51. PubMed ID: 8566036
[TBL] [Abstract][Full Text] [Related]
13. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
Browning MJ; Huang AS; Reiss CS
J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T lymphocytes reactive with vesicular stomatitis virus: analysis of specificity with monoclonal antibodies directed to the viral glycoprotein.
Lefrancois L; Lyles DS
J Immunol; 1983 Mar; 130(3):1408-12. PubMed ID: 6185583
[TBL] [Abstract][Full Text] [Related]
15. Antigen-presenting B cells: efficient uptake and presentation by activated B cells for induction of cytotoxic T lymphocytes against vesicular stomatitis virus.
Ciavarra RP; Burgess DH
Cell Immunol; 1988 Jun; 114(1):27-40. PubMed ID: 2836071
[TBL] [Abstract][Full Text] [Related]
16. The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease.
Lim H; In HJ; Lee JA; Sik Yoo J; Lee SW; Chung GT; Choi YK; Chung JK; Cho SJ; Lee JW
Vaccine; 2018 Jun; 36(24):3445-3452. PubMed ID: 29739716
[TBL] [Abstract][Full Text] [Related]
17. Interferon gamma-producing gammadelta T cell-dependent antibody isotype switching in the absence of germinal center formation during virus infection.
Maloy KJ; Odermatt B; Hengartner H; Zinkernagel RM
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1160-5. PubMed ID: 9448302
[TBL] [Abstract][Full Text] [Related]
18. VSV G protein induces murine cytolytic T lymphocytes.
Reiss CS; Chen SS; Huang AS; Doherty R
Microb Pathog; 1986 Jun; 1(3):261-7. PubMed ID: 2854599
[TBL] [Abstract][Full Text] [Related]
19. Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens.
Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Bavananthasivam J; Nagy É; Petrik JJ; Sharif S
Vaccine; 2018 Jun; 36(27):3908-3916. PubMed ID: 29853199
[TBL] [Abstract][Full Text] [Related]
20. Serum neutralizing antibody titers in dairy cattle administered an inactivated vesicular stomatitis virus vaccine.
Gearhart MA; Webb PA; Knight AP; Salman MD; Smith JA; Erickson GA
J Am Vet Med Assoc; 1987 Oct; 191(7):819-22. PubMed ID: 2824413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
